ARTICLE | Company News
Horizon Discovery, Redx Pharma deal
October 12, 2015 7:00 AM UTC
The companies partnered to develop Redx’s pan-RAF inhibitor program to treat cancer. Horizon will use its gene editing, cell line and drug discovery technologies to explore the mechanism of Redx’s sma...